Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report

Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yano, Shungo, Miyagami, Taiju, Furusaka, Takayuki, Kano, Nagamasa, Naito, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979965/
https://www.ncbi.nlm.nih.gov/pubmed/36873062
http://dx.doi.org/10.1002/ccr3.7001
_version_ 1784899826085789696
author Yano, Shungo
Miyagami, Taiju
Furusaka, Takayuki
Kano, Nagamasa
Naito, Toshio
author_facet Yano, Shungo
Miyagami, Taiju
Furusaka, Takayuki
Kano, Nagamasa
Naito, Toshio
author_sort Yano, Shungo
collection PubMed
description Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution.
format Online
Article
Text
id pubmed-9979965
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99799652023-03-03 Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report Yano, Shungo Miyagami, Taiju Furusaka, Takayuki Kano, Nagamasa Naito, Toshio Clin Case Rep Case Images Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution. John Wiley and Sons Inc. 2023-03-02 /pmc/articles/PMC9979965/ /pubmed/36873062 http://dx.doi.org/10.1002/ccr3.7001 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Images
Yano, Shungo
Miyagami, Taiju
Furusaka, Takayuki
Kano, Nagamasa
Naito, Toshio
Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
title Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
title_full Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
title_fullStr Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
title_full_unstemmed Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
title_short Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
title_sort concurrent hypereosinophilic syndrome and deep vein thrombosis after pfizer‐biontech covid‐19 vaccination: a case report
topic Case Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979965/
https://www.ncbi.nlm.nih.gov/pubmed/36873062
http://dx.doi.org/10.1002/ccr3.7001
work_keys_str_mv AT yanoshungo concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport
AT miyagamitaiju concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport
AT furusakatakayuki concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport
AT kanonagamasa concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport
AT naitotoshio concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport

Ejemplares similares